Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma

Affiliations

• ¹ Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK s.araf@qmul.ac.uk.
• ² Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
• ³ Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
• ⁴ Institute of Pathology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
• ⁵ Department of Nuclear Medicine, Cantonal Hospital St Gallen, St Gallen, Switzerland.
• ⁶ King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.
• ⁷ Evolution and Cancer Laboratory, Barts Cancer Institute, Queen Mary University of London, London, UK.
• ⁸ Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.
• ⁹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
• ¹⁰ Cancer Research UK Centre, University of Southampton, Southampton, UK.
• ¹¹ Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK j.fitzgibbon@qmul.ac.uk.
• ¹² Clinic for Medical Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland.